Rosuvastatin Completed Phase 3 Trials for Cardiovascular Heart Disease / Atherosclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00127218High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly
NCT02546323A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis
NCT00115830Rho Kinase in Patients With Atherosclerosis
NCT01936805ROsuvastatin LOading and Clinical Outcomes Trial